These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16822721)

  • 1. Diabetes and cardiovascular disease. Introduction.
    Chait A
    Atheroscler Suppl; 2006 Aug; 7(4):1-4. PubMed ID: 16822721
    [No Abstract]   [Full Text] [Related]  

  • 2. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.
    Quispe R; Martin SS; Jones SR
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering.
    Mayer-Davis EJ; Ma B; Lawson A; D'Agostino RB; Liese AD; Bell RA; Dabelea D; Dolan L; Pettitt DJ; Rodriguez BL; Williams D;
    Metab Syndr Relat Disord; 2009 Apr; 7(2):89-95. PubMed ID: 18847385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome.
    Opie LH
    Circulation; 2007 Jan; 115(3):e32-5. PubMed ID: 17242286
    [No Abstract]   [Full Text] [Related]  

  • 5. American College of Endocrinology position statement on the insulin resistance syndrome.
    Einhorn D; Reaven GM; Cobin RH; Ford E; Ganda OP; Handelsman Y; Hellman R; Jellinger PS; Kendall D; Krauss RM; Neufeld ND; Petak SM; Rodbard HW; Seibel JA; Smith DA; Wilson PW
    Endocr Pract; 2003; 9(3):237-52. PubMed ID: 12924350
    [No Abstract]   [Full Text] [Related]  

  • 6. The metabolic syndrome in type 2 diabetic subjects in Gorgan, Iran.
    Marjani A; Mojerloo M
    J Pak Med Assoc; 2011 May; 61(5):458-61. PubMed ID: 22204179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk.
    Salazar MR; Carbajal HA; Espeche WG; Dulbecco CA; Aizpurúa M; Marillet AG; Echeverría RF; Reaven GM
    Diab Vasc Dis Res; 2011 Apr; 8(2):109-16. PubMed ID: 21562062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lipid triad, or how to reduce residual cardiovascular risk?
    Girard-Mauduit S
    Ann Endocrinol (Paris); 2010 Mar; 71(2):89-94. PubMed ID: 20303470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
    Amihăesei IC; Chelaru L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.
    Cruz ML; Weigensberg MJ; Huang TT; Ball G; Shaibi GQ; Goran MI
    J Clin Endocrinol Metab; 2004 Jan; 89(1):108-13. PubMed ID: 14715836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic syndrome: protective obesity].
    Nau JY
    Rev Med Suisse; 2010 Mar; 6(241):644-5. PubMed ID: 20408371
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
    Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
    Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
    Hodge AM; Dowse GK; Zimmet PZ
    Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract]   [Full Text] [Related]  

  • 15. Obesity indices and major components of metabolic syndrome in young adult Arab subjects.
    Al-Shayji IA; Akanji AO
    Ann Nutr Metab; 2004; 48(1):1-7. PubMed ID: 14639040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proinsulin as marker -- what for?].
    Kayser T
    Dtsch Med Wochenschr; 2005 Apr; 130(14):903. PubMed ID: 15800827
    [No Abstract]   [Full Text] [Related]  

  • 18. Obesity, metabolic syndrome, and cardiovascular disease.
    Grundy SM
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2595-600. PubMed ID: 15181029
    [No Abstract]   [Full Text] [Related]  

  • 19. Use it or lose it: exercise, diabetes and CVD.
    Gottlieb SH
    Diabetes Forecast; 2002 May; 55(5):39-41. PubMed ID: 14964157
    [No Abstract]   [Full Text] [Related]  

  • 20. The Editor's Roundtable: the metabolic syndrome.
    Friedewald VE; Grundy S; Gotto AM; Haffner S; Denke MA; Hollander P; Roberts WC
    Am J Cardiol; 2007 Feb; 99(3):382-9. PubMed ID: 17261403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.